Pfizer bows out of developing cardio drug, returns rights to Ionis Pharmaceuticals February 1, 2022 Auto Bot BioPharma, biopharma nl, cardiovascular disease, New York, News, Pfizer 0 Sometimes even a clinical trial where the endpoints have been met may not give the […]